Notice2021-19027
Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 3, 2021
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that two meetings are scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meetings will be open to the public via WebEx and teleconference; a pre-registered public comment session will be held during both meetings. Pre-registration is required for members of the public who wish to attend the meetings via WebEx/teleconference. Individuals who wish to send in their written public comment should send an email to CARB@hhs.gov. Registration information is available on the website http://www.hhs.gov/paccarb and must be completed by October 1, 2021 for the October 6, 2021 virtual Public Meeting; and, by November 29, 2021 for the November 30-December 1, 2021 virtual Public Meeting. Additional information about registering for the meeting and providing public comment can be obtained at http://www.hhs.gov/paccarb on the Upcoming Meetings page.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 169 (Friday, September 3, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 169 (Friday, September 3, 2021)]
[Notices]
[Pages 49551-49552]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19027]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that two meetings are scheduled to be held for the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).
The meetings will be open to the public via WebEx and teleconference; a
pre-registered public comment session will be held during both
meetings. Pre-registration is required for members of the public who
wish to attend the meetings via WebEx/teleconference. Individuals who
wish to send in their written public comment should send an email to
<a href="/cdn-cgi/l/email-protection#7734362535371f1f0459101801"><span class="__cf_email__" data-cfemail="2764667565674f4f5409404851">[email protected]</span></a>. Registration information is available on the website
<a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> and must be completed by October 1, 2021 for
the October 6, 2021 virtual Public Meeting; and, by November 29, 2021
for the November 30-December 1, 2021 virtual Public Meeting. Additional
information about registering for the meeting and providing public
comment can be obtained at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> on the Upcoming
Meetings page.
DATES: The October meeting is scheduled to be held on October 6, 2021,
from 10:00 a.m. to 11:00 a.m. ET (times are tentative and subject to
change). The November/December meeting is scheduled to be held on
November 30, 2021 from 10:00 a.m. to 3:00 p.m. and December 1, 2021,
from 10:00 a.m. to 3:00 p.m. ET (times are tentative and subject to
change). The confirmed times and agenda items for both meetings will be
posted on the website for the PACCARB at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>
when this information becomes available. Pre-registration for attending
the meeting is strongly suggested and should be completed no later than
October 1, 2021 for the October meeting and November 29, 2021 for the
November/December meeting.
ADDRESSES: Instructions regarding attending this meeting virtually will
be posted at least one week prior to the meeting at: <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L616, Switzer Building,
330 C St. SW, Washington, DC 20024. Phone: 202-746-1512; Email:
<a href="/cdn-cgi/l/email-protection#f2b1b3a0b0b29a9a81dc959d84"><span class="__cf_email__" data-cfemail="84c7c5d6c6c4ececf7aae3ebf2">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council
are governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary regarding programs and policies
intended to reduce or combat antibiotic-resistant bacteria that may
present a public health threat and improve capabilities to prevent,
diagnose, mitigate, or treat such resistance. The PACCARB shall
function solely for advisory purposes.
Such advice, information, and recommendations may be related to
improving: The effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The October 6, 2021 public meeting will be held virtually and is
dedicated to deliberation and vote of the letter with recommendations
from the Immediate Action Subcommittee of the Advisory Council. The
meeting agenda will be posted on the PACCARB website at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when it has been finalized. All agenda items are
tentative and subject to change.
The November 31, 2021 and December 1, 2021 public meeting will be
held virtually and will be dedicated to addressing the current
situation regarding antimicrobial resistance as well as to a
presentation from the National Academies of Sciences, Engineering, and
Medicine on their report, Examining the Long-term Health and Economic
Effects of Antimicrobial Resistance in the United States. The meeting
agenda will be posted on the PACCARB website at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when it has been finalized. All agenda items are tentative and
subject to change.
Instructions regarding attending both meetings virtually will be
posted one
[[Page 49552]]
week prior to each meeting at: <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
Members of the public will have the opportunity to provide comments
live during the October meeting via conference line by pre-registering
online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>. Pre-registration is required for
participation in this session with limited spots available. Written
public comments can also be emailed to <a href="/cdn-cgi/l/email-protection#185b594a5a5870706b367f776e"><span class="__cf_email__" data-cfemail="4605071404062e2e3568212930">[email protected]</span></a> by midnight October
1, 2021 and should be limited to no more than one page. All public
comments received prior to October 1, 2021, will be provided to
Advisory Council members.
Members of the public will have the opportunity to provide comments
live during the November 30, 2021 and December 1, 2021 public meeting
via conference line by pre-registering online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>. There will be two separate sessions available for public
comment: An Innovation Spotlight will be held on November 30, 2021
where companies and/or organizations involved in combating antibiotic
resistance have an opportunity to present their work to members of the
Advisory Council; and on December 1, 2021, where all members of the
general public are welcome to provide oral comment during this separate
session. Pre-registration is required for participation in these
sessions with limited spots available. Further information about these
two sessions can be found online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>. Written
public comments can also be emailed to <a href="/cdn-cgi/l/email-protection#d99a988b9b99b1b1aaf7beb6af"><span class="__cf_email__" data-cfemail="b8fbf9eafaf8d0d0cb96dfd7ce">[email protected]</span></a> by midnight
November 29, 2021 and should be limited to no more than one page. All
public comments received prior to November 29, 2021, will be provided
to Advisory Council members.
Dated: August 26, 2021.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2021-19027 Filed 9-2-21; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 3, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.